EmPLiCS: An empirical approach for structure-based design of natural peptide drugs

被引:4
|
作者
Ishida, H [1 ]
Shirai, T [1 ]
Matsuda, Y [1 ]
Kato, Y [1 ]
Ohno, M [1 ]
Isaji, T [1 ]
Yamane, T [1 ]
机构
[1] Nagoya Univ, Grad Sch Engn, Dept Biotechnol & Biomat Chem, Chikusa Ku, Nagoya, Aichi 4648603, Japan
来源
JOURNAL OF BIOCHEMISTRY | 2000年 / 128卷 / 04期
关键词
computer program; peptide drug; protein evolution; rational drug design;
D O I
10.1093/oxfordjournals.jbchem.a022788
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The computer implementation of a peptide drug-design strategy has been developed. The system is named EmPLiCS (Empirical Peptide Ligand Construction System) according to the strategy of the system, which searches for peptide-ligand structures by referring to empirical rules that are derived from known protein 3D structures. The system was tested on several known peptide-protein complexes. The results demonstrated the ability of this system to detect key residues of peptides that are crucial for interaction with their specific proteins. The system also showed the ability to detect the main chain trace of these peptides, Some of the main chain atoms were detected even though the complete primary structures were not reproduced, suggesting that main chain structure is important in peptide-protein recognition. The results of the present study demonstrated that the empirical rules-based system can generate significant information for use in the design of natural peptide drugs.
引用
收藏
页码:561 / 574
页数:14
相关论文
共 50 条
  • [21] A STRUCTURE-BASED APPROACH TO MEARSURING ADAPTABILITY OF PRODUCT DESIGN
    Shao, X. Y.
    Cheng, Q.
    Zhang, G. J.
    Li, P. G.
    Gu, P. H.
    DETC 2008: PROCEEDINGS OF THE ASME INTERNATIONAL DESIGN ENGINEERING TECHNICAL CONFERENCES AND COMPUTERS AND INFORMATION IN ENGINEERING CONFERENCE, VOL 1, PTS A AND B: 34TH DESIGN AUTOMATION CONFERENCE, 2009, : 342 - 350
  • [22] Ligand and Structure-Based Approaches for the Identification of Peptide Deformylase Inhibitors as Antibacterial Drugs
    Gao, Jian
    Liang, Li
    Zhu, Yasheng
    Qiu, Shengzhi
    Wang, Tao
    Zhang, Ling
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (07):
  • [23] Structure-based design
    Charlotte Harrison
    Nature Reviews Drug Discovery, 2011, 10 : 658 - 658
  • [24] Structure-based design
    Harrison, Charlotte
    NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (09) : 658 - 658
  • [25] Structure-based design of a novel peptide inhibitor of HIV-1 integrase: A computer modeling approach
    Rao, GS
    Bhatnagar, S
    Ahuja, V
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2002, 20 (01): : 31 - 38
  • [26] ENPDA:: an evolutionary structure-based de novo peptide design algorithm
    Belda, I
    Madurga, S
    Llorà, X
    Martinell, M
    Tarragó, T
    Piqueras, MG
    Nicolás, E
    Giralt, E
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2005, 19 (08) : 585 - 601
  • [27] Structure-based design of an indolicidin peptide analogue with increased protease stability
    Rozek, A
    Powers, JPS
    Friedrich, CL
    Hancock, REW
    BIOCHEMISTRY, 2003, 42 (48) : 14130 - 14138
  • [28] Structure-Based Design of New AIDS Drugs: Overcoming Drug Resistance
    Das, Kalyan
    Clark, Arthur D., Jr.
    Lewi, Paul J.
    Hughes, Stephen H.
    Janssen, Paul A. J.
    Arnold, Eddy
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2005, 61 : C119 - C119
  • [29] Structure-based Drugs Design Studies on Spleen Tyrosine Kinase Inhibitors
    Assis, Leticia Cristina
    Garcia, Leticia Santos
    Mancini, Daiana Teixeira
    Assis, Tamiris Maria
    Silva, Daniela Rodrigues
    Cardoso, Giovanna Gajo
    de Castro, Alexandre Alves
    Ramalho, Teodorico Castro
    Ferreira da Cunha, Elaine Fontes
    LETTERS IN DRUG DESIGN & DISCOVERY, 2016, 13 (09) : 845 - 858
  • [30] Structure-based design of non-peptide HIV protease inhibitors
    Ghosh, AK
    Shin, D
    Swanson, L
    Krishnan, K
    Cho, H
    Hussain, KA
    Walters, DE
    Holland, L
    Buthod, J
    FARMACO, 2001, 56 (1-2): : 29 - 32